Column Group Management LP, 10% Owner, Ten Percent Owner Other at NGM BIOPHARMACEUTICALS INC (NGM), bought 16,818 shares at $11.99 ($202K) on 2019-11-04, disclosed to the SEC on 2019-11-06.
Open-market purchase of $202k NGM by 10% Owner, Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.99 | 8,409 | $101K | 50.0% |
| 2 | $11.99 | 8,409 | $101K | 50.0% |
| Total | $11.99 avg | 16,818 | $202K | 100% |
| Filing → |
| NGM | BUY | 2020-04-07 | $3.9M | — | Filing → |
| NGM | BUY | 2019-08-05 | $61K | — | Filing → |
| NGM | BUY | 2019-04-10 | $30.2M | — | Filing → |